Abstract
Introduction Diabetes mellitus (DM) is a metabolic disorder with inappropriate hyperglycemia either due to an absolute or relative deficiency of insulin secretion or reduction in the biologic effectiveness of insulin or both. An inflammatory basis for Diabetes & its complications has attracted interest. Among several markers of inflammation, C reactive protein (CRP) is found to be significant in people with diabetes. Diabetic nephropathy may be associated with abnormally high levels of CRP.
Materials & Methods This study was performed for 1 year over 100 type 2 diabetic patients (n=100) aged 30-70 years in Calcutta National Medical College & Hospital. Necessary clinical & Diabetes related laboratory investigations were done as the routine procedure.
Results Among 100 study population, all macro-albuminuria patients were found to have high CRP. 63% of Stage 3 chronic kidney disease (CKD) patients were having high CRP in our study. High CRP values were also found among patients with higher spot urine ACR (329.50±259.40 mg/gram).(P<0.05)
Conclusion CRP is a marker which increased in inflammatory reactions. Low grade inflammation as indicated by high CRP was an important predictor of diabetic nephropathy.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
THIS IS A MEDICAL STUDENT WORK, ETHICAL BOARD OF CALCUTTA NATIONAL MEDICAL COLLEGE GAVE THE ETHICAL APPROVAL. THE ETHICAL APPROVAL IS ATTACHED AT THE LAST OF THE PAPER MANUSCRIPT.
Funding Statement
THIS RESEARCH IS NOT A FUNDED RESEARCH.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
THE ETHICS BOARD OF CALCUTTA NATIONAL MEDICAL COLLEGE HAS APPROVED THE WORK AND THEIR APPROVAL CERTIFICATE IS ATTACHED AT THE LAST OF THE MANUSCRIPT PAPER.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
WE HAVE INCLUDED ALL THE DATA FROM THE TEST REPORTS OF THE PATIENT. WE HAVE USED ANNOVA STATISTICAL SOFTWARE FOR STATISTICAL ANALYSIS. ALL THE DATA AND CALCULATIONS ARE CORRECT AND VALID. TESTS ARE DONE FROM VALID LABS.PATIENT CONSENT IS ALSO TAKEN.
